Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| LEMAITRE VASCULAR INCLMAT · Entity 1927 | Director · Chairman and CEO | September 03, 2026 | September 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
LEMAITRE VASCULAR INC
Report date September 03, 2026 · Filed September 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 54.005 |
Reported balance
After 2026-09-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 54.005 F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 53.2963 |
Reported balance
After 2026-09-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-09-03 · Grant · Acquired 4.6726 · Balance 53.2963 F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.3344 |
Reported balance
After 2026-09-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-03 · Grant · Acquired 7.9884 · Balance 65.3344 F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 70.4281 |
Reported balance
After 2026-09-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-03 · Grant · Acquired 9.5728 · Balance 70.4281 F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 65.0639 |
Reported balance
After 2026-09-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-09-03 · Grant · Acquired 11.6845 · Balance 65.0639 F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 67.0809 |
Reported balance
After 2026-09-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-09-03 · Grant · Acquired 13.2391 · Balance 67.0809 F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
| Dividend Equivalent RightsSEC Table II · derivative / convertible security | Direct | 50.6104 |
Reported balance
After 2026-09-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-09-03 · Grant · Acquired 19.5865 · Balance 50.6104 F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F6: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F7: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2024 Filed Sep 3, 2024 23:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.0067 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028305 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71.7678 Underlying: Common Stock · 8.0067 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.0067 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028305 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72.4765 Underlying: Common Stock · 8.0067 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.2377 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028305 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78.3583 Underlying: Common Stock · 5.2377 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 3.6312 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028305 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71.9342 Underlying: Common Stock · 3.6312 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| August 29, 2024 Filed Sep 3, 2024 23:40 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 1.9357 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-028305 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53.2731 Underlying: Common Stock · 1.9357 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| July 16, 2024 Filed Jul 18, 2024 22:22 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 57,372 | $86.69 | $4,973,790.96 |
DisclosureSEC source: 0001437749-24-023010 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,900,956 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $86.45 to $86.98. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:20 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 27,030 | $86.27 | $2,331,907.83 |
DisclosureSEC source: 0001437749-24-022817 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,958,328 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $86.16 to $86.41. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| July 12, 2024 Filed Jul 16, 2024 20:20 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 12,976 | $86.07 | $1,116,844.32 |
DisclosureSEC source: 0001437749-24-022817 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,985,358 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $86.01 to $86.14. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.246 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22.3788 Underlying: Common Stock · 10.246 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.9898 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63.7611 Underlying: Common Stock · 8.9898 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 8.9898 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64.4698 Underlying: Common Stock · 8.9898 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 5.8814 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73.1206 Underlying: Common Stock · 5.8814 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.0765 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68.303 Underlying: Common Stock · 4.0765 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 30, 2024 Filed Jun 3, 2024 20:41 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.1735 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-019054 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51.3374 Underlying: Common Stock · 2.1735 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 40,968 | $76.80 | $3,146,371.08 |
DisclosureSEC source: 0001437749-24-017053 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,998,334 F2 · price: Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.60 to $77.07. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 14, 2024 Filed May 15, 2024 20:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GiftCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-017053 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,039,302 Read SEC document |
| May 13, 2024 Filed May 15, 2024 20:11 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 35,826 | $76.42 | $2,737,686.78 |
DisclosureSEC source: 0001437749-24-017053 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,043,302 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.24 to $76.60. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 08, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 8,000 | $75.30 | $602,427.20 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,079,128 F7 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.9289 to $75.66. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,256 | $75.86 | $1,536,539.14 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,087,128 F6 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.55 to $76.085. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 07, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 26,044 | $75.24 | $1,959,521.91 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,107,384 F5 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.5584 to $75.5484. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 16,200 | $75.94 | $1,230,237.72 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,133,428 F4 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $75.6846 to $76.23. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 29,500 | $75.23 | $2,219,308.60 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,149,628 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $74.68 to $75.635. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| May 06, 2024 Filed May 8, 2024 20:51 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 23,206 | $76.12 | $1,766,466.25 |
DisclosureSEC source: 0001437749-24-015399 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,179,128 F1 · price: Adoption date of referenced 10b5-1(c) plan is: 06-02-2023 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $76.01 to $76.24. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 12.1328 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12.1328 Underlying: Common Stock · 12.1328 shares Expires not disclosed F6 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F6 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.6452 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54.7713 Underlying: Common Stock · 10.6452 shares Expires not disclosed F5 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F5 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Share Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 10.6452 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55.48 Underlying: Common Stock · 10.6452 shares Expires not disclosed F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 6.9643 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67.2392 Underlying: Common Stock · 6.9643 shares Expires not disclosed F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 4.827 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64.2265 Underlying: Common Stock · 4.827 shares Expires not disclosed F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/2/2020 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 28, 2024 Filed Apr 1, 2024 21:18 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantDividend Equivalent Rights · Derivative | 2.5739 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-010415 · rdgdoc.xml · derivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49.1639 Underlying: Common Stock · 2.5739 shares Expires not disclosed F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/20/2019 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:43 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,075 | $0.00 Strike: $47.19 | $0.00 |
DisclosureSEC source: 0001437749-24-009454 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,344 Underlying: Common Stock · 7,075 shares Expires 2029-12-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the forth anniversary. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:43 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,733 | $0.00 Strike: $48.60 | $0.00 |
DisclosureSEC source: 0001437749-24-009454 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,467 Underlying: Common Stock · 7,733 shares Expires 2028-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a four-year period at a rate of 25% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the forth anniversary. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:43 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,733 | $48.60 | $375,823.80 |
DisclosureSEC source: 0001437749-24-009454 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,202,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 22, 2024 Filed Mar 26, 2024 21:43 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,075 | $47.19 | $333,869.25 |
DisclosureSEC source: 0001437749-24-009454 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,194,601 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 3,800 | $68.68 | $260,984.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 12 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,187,526 F12 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.54 to $68.85. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 32,800 | $67.95 | $2,228,760.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 11 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,191,326 F11 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.53 to $68.52. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 950 | $69.64 | $66,158.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 10 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,224,126 F10 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $68.92 to $69.82. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,200 | $68.04 | $1,374,408.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 9 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,225,076 F9 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.74 to $68.56. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 15,869 | $67.51 | $1,071,316.19 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 8 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,245,276 F8 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $66.74 to $67.73. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionDividend Equivalent Rights · Derivative | 14.7087 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · derivative · entry 13 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44.1261 Underlying: Common Stock · 14.7087 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F13 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F13 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. F13 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Tax withholdingCommon Stock | 432 | $70.00 | $30,240.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 7 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,261,145 F7 · shares: These shares represent shares withheld by the issuer to satisfy tax withholding obligations incurred upon the vesting of performance stock units awarded to the reporting person on December 12, 2022. This transaction is considered an exempt sale pursuant to Rule 16b-3(e) promulgated under the Securities Exchange Act of 1934. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 14 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 6 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,261,577 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | GrantCommon Stock | 5,828 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 5 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,261,563 F5 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 25% upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next three years. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 2 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,255,735 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents shares from the release of fractional dividend equivalent rights returned to company. F4 · price: Represents shares from the release of fractional dividend equivalent rights returned to company. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 5,984 | $70.14 | $419,717.76 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,255,737 F3 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $70.00 to $70.61. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 20,575 | $69.69 | $1,433,871.75 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,261,721 F2 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $69.00 to $69.98. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| February 29, 2024 Filed Mar 5, 2024 02:45 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | SaleCommon Stock | 1,300 | $68.37 | $88,881.00 |
DisclosureSEC source: 0001437749-24-006521 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,282,296 F1 · price: The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $67.98 to $68.95. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 20:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 8,610 | $0.00 Strike: $35.48 | $0.00 |
DisclosureSEC source: 0001437749-23-035378 · rdgdoc.xml · derivative · entry 4 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,610 Underlying: Common Stock · 8,610 shares Expires 2026-12-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 20:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,836 | $0.00 Strike: $37.29 | $0.00 |
DisclosureSEC source: 0001437749-23-035378 · rdgdoc.xml · derivative · entry 3 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,672 Underlying: Common Stock · 7,836 shares Expires 2027-12-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vests in equal annual installments over the remaining four years, with the final vesting occurring on the 11th month after the fourth anniversary. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 20:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 8,610 | $35.48 | $305,482.80 |
DisclosureSEC source: 0001437749-23-035378 · rdgdoc.xml · nonDerivative · entry 2 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,283,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
| December 26, 2023 Filed Dec 27, 2023 20:12 UTC | LEMAITRE VASCULAR INC LMAT · Entity 1927 | Exercise / conversionCommon Stock | 7,836 | $37.29 | $292,204.44 |
DisclosureSEC source: 0001437749-23-035378 · rdgdoc.xml · nonDerivative · entry 1 LeMaitre George W · CIK 0001365737 · Director · Chairman and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,274,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.